Cargando…
Tackling the blind spot of poor-quality medicines in Universal Health Coverage
BACKGROUND: Universal Health Coverage (UHC) is challenged by the prevalence of poor-quality medicines, those that either do not meet required specifications (substandard) or are outrightly fraudulent (falsified), especially in Low- and Middle-Income Countries, LMICs. Whereas poor-quality medicines a...
Autores principales: | Orubu, E. S. F., Ching, C., Zaman, M. H., Wirtz, V. J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7350647/ https://www.ncbi.nlm.nih.gov/pubmed/32670594 http://dx.doi.org/10.1186/s40545-020-00208-4 |
Ejemplares similares
-
Essential medicines for universal health coverage
por: Wirtz, Veronika J, et al.
Publicado: (2017) -
The need for comprehensive and multidisciplinary training in substandard and falsified medicines for pharmacists
por: Ferrario, Alessandra, et al.
Publicado: (2019) -
Path to universal health coverage is intrinsically linked to effectively tackling noncommunicable diseases
por: Lahariya, C
Publicado: (2022) -
Bacterial antibiotic resistance development and mutagenesis following exposure to subminimal inhibitory concentrations of fluoroquinolones in vitro: a systematic literature review protocol
por: Ching, Carly, et al.
Publicado: (2019) -
Importance of medicine quality in achieving universal health coverage
por: Ozawa, Sachiko, et al.
Publicado: (2020)